MDS Virtual Congress 2020 » Parkinson's Disease: Neuroimaging

Aberrant resting-state functional connectivity in cognitively unimpaired patients with Parkinson´s disease and freezing of gait

A. Martin-Bastida, M. Delgado-Alvarado, I. Navalpotro-Gomez, C. Caballero-Gaudes, M. Carreiras, M. Rodriguez-Oroz (Pamplona, Spain)

Abnormal Cerebral Glucose Metabolism and Dopaminergic Dysfunction in Patients with Parkinson’s Disease with Bilateral Onset

P. Wu, L. Li, J. Lu, Q. Shi, Y. Zhu, J. Xiao, C. Zuo (Shanghai, China)

Abnormal network interconnections dynamics correlate with levodopa-induced dyskinesia in Parkinson’s disease

Q. Si, Y. Yuan, C. Gan, M. Wang, L. Wang, K. Ma, K. Zhang (Nanjing, China)

Alpha-synuclein preformed fibril (PFF)-triggered synucleinopathy recapitulates neurochemical features of human PD: A PET study in rats

C. Sortwell, J. Patterson, C. Kemp, K. Miller, A. Stoll, M. Duffy, K. Luk, V. Sossi (Grand Rapids, MI, USA)

Alterations in functional networks contribute to depression in Parkinson’s disease: A resting-state functional magnetic resonance imaging study

Y. Qiu, L. Wang (Guangzhou, China)

Altered interhemispheric synchrony in Parkinson’s disease patients with levodopa-induced dyskinesias

C.T Gan, M. Wang, QQ. Si, Y.S Yuan, Y. Zhi, L.N Wang, K.W Ma (Nanjing, China)

Altered metabolic and functional resting state activity in cognitively unimpaired and impaired Parkinson’s disease patients

M. Ruppert, A. Greuel, M. Tahmasian, K. Steidel, F. Maier, J. Hammes, T. van Eimeren, L. Timmermann, M. Tittgemeyer, A. Drzezga, C. Eggers (Marburg, Germany)

Application of substantia nigra feature extraction in the progression of Parkinson’s disease based on magnitude image of susceptibility weighted imaging

Q. Ren, B. Zhang, J. Zhang, X. Shuai, X. Nan, Y. Ge, X. Meng, C. Zhao (Qingdao, China)

Association between motor symptoms and striatal VMAT2 binding in PD: a PET study

S.Y Liu, H.W Qiao, C.Y Qi, Z.Q Gu, O. Barret, K. Marek, G. Tamagnan, P. Chan (Beijing, China)

Association Between Ventricle/Brain Volumes and Mobility Metrics in Parkinson’s Disease

A. Ragothaman, A. Giritharan, M. Mancini, O. Miranda-Dominguez, D. Fair, J. Nutt, F. Horak (Portland, OR, USA)

Automated pattern based classification in neuropathology proven parkinsonism

K. Schindlbeck, D. Gupta, C. Tang, S. O'Shea, K. Poston, V. Dhawan, J.P Vonsattel, S. Fahn, D. Eidelberg (New York, NY, USA)

Automatic Detection of Nigrosome Degeneration in Susceptibility-Weighted MRI for Computer-Aided Diagnosis of Parkinson’s Disease Using Machine Learning

B. Garcia-Santa Cruz, A. Husch, F. Hertel (Luxembourg, Luxembourg)

Body weight and brainstem raphe echogenicity in patients with Parkinson’s disease

J.S Baik, H.I Ma (Seoul, Republic of Korea)

Brain atrophy progression in de novo Parkinson’s disease

C. Tremblay, S. Rahayel, A. Vo, A. Dagher (Montreal, QC, Canada)

Brain cholinergic dysfunction in patients with isolated REM sleep behavior disorder: A clinical and 11C-Donepezil PET follow-up study

K. Stær, A. Iranzo, M. Stokholm, K. Østergaard, M. Serradell, M. Otto, K. Svendsen, A. Pla, D. Vilas, J. Santamaria, A. Møller, C. Gaig, D. Brooks, P. Borghammer, E. Tolosa, N. Pavese (Aarhus N, Denmark)

Cortical thickness and volume to automatically identify Parkinson’s patients using SVM

L. Squarcina, G. Dossi, M. Rango (Milan, Italy)

Decreased Availability of Adenosine 2A Receptors in the Caudate in Patients with Early Stage Parkinson’s Disease

I. Waggan, E. Rissanen, J. Tuisku, J. Joutsa, S. Helin, R. Parkkola, J. Rinne, L. Airas (Turku, Finland)

Deep learning-based automatic nigrosome 1 segmentation on 3T susceptibility-weighted MRI

J.M Kim, J.H Choi, Y.J Bae, B.S Choi, Y.H Park, I.D Yun (Seongnam, Republic of Korea)

Diagnostic value of vagus nerve ultrasound in Parkinson’s disease

M. Abo Srea, N.A Kishk, R. Soliman, A. Alsayyad, M. Oraby (Beni-Suef, Egypt)

Diffusion Magnetic Resonance Imaging with Neurite Orientation and Dispersion Imaging (NODDI) Detects Early Localized Cortex Disruption in Parkinson’s Disease

W. Sweidan, N. Seraji-Bozorgzad, J. Stanley, E. George (Detroit, MI, USA)

Disrupted functional brain connectome at the early non-freezing stage of Parkinson’s disease patients with freezing of gait

N. Li, X. Suo, J. Zhang, D. Lei, L. Wang, J. Li, J. Peng, L. Duan, C. Chen, Q. Gong, R. Peng (Chengdu, China)

Distinct compensatory and maladaptive wiring patterns in genotypic Parkinson’s disease

K. Schindlbeck, A. Vo, N. Nguyen, A. Rommal, C. Tang, M. Niethammer, V. Dhawan, R. Saunders-Pullman, S. Bressman, D. Eidelberg (New York, NY, USA)

Dopaminergic denervation in de-novo Parkinson’s disease. Does functional somatotopy plays a role?

J.A Pineda-Pardo, A. Sánchez-Ferro, M. HM Monje, J.A Obeso (Móstoles, Spain)

Dual hit model of Parkinson’s disease propagation using MRI biomarkers and partial least squares path modeling

N. Pyatigorskaya, L. Yahia-Cherif, R. Valabregue, R. Gaurav, F. Gargouri, C. Ewenczyk, C. Gallea, S. Fernandez-Vidal, I. Arnulf, M. Vidailhet, S. Lehericy (Paris, France)

Dysfunction in superior frontal gyrus associated with diphasic dyskinesia in Parkinson’s disease

S. yuting, Z. kezhong (Nanjing, China)

Effect of globus pallidus interna deep brain stimulation on functional connectivity in patients with Parkinson’s disease

CC. Zhang, N.Y He, J. Li, Y.J Lai, L.B Wang, B.M Sun, V. Voon, F.H Yan, D.Y Li (Shanghai, China)

Elevated nigral iron is associated with low plasma serotonin in Parkinson’s disease

L. Jellen, A. Snyder, G. Du, M. Lewis, E. Wang, C. Capan, P. Brundin, L. Brundin, J. Connor, X. Huang (Hershey, PA, USA)

Exploring dopamine transporter single-photon emission computed tomography quantification as a measure of disease progression in idiopathic Parkinson’s disease

J. Gurwell, R. El Khouli, G. Quintero, J. Slevin, M. Yazell, C. van Horne (Lexington, KY, USA)

FDG PET and MIBG scintigraphy in the differential diagnosis of parkinsonism: a head-to-head comparison

N. Schröter, J. Brumberg, G. Blazhenets, L. Frings, J. Volkmann, C. Lapa, W. Jost, I. Isaias, P. Meyer (Freiburg, Germany)

Frailty as clinical modulator of brain damage and progression in Parkinson’s disease

A. Pilotto, A. Lupini, F. Savoldi, F. Conforti, G. Giannì, A. Imarisio, S. Gipponi, E. Cottini, A. Scalvini, S. Masciocchi, S. Nocivelli, R. Grasso, R. Turrone, M. Rizzetti, A. Padovani (Brescia, Italy)

Free Water in Corpus Callosum is Sensitive to Parkinson’s Disease-related Cognitive Decline

G. Brown, G. Du, M. Lewis, X. Liu, E. Lee, P. Eslinger, L. Kong, J. Hakun, X. Huang (Hershey, PA, USA)

Functional connectivity and volumetric data improve prediction of DBS outcomes

J. Younce, M. Campbell, J. Perlmutter, S. Norris (St Louis, MO, USA)

Functional connectivity of brain autonomic centers reveals associations with cardiovascular autonomic dysfunction in Parkinson’s disease

M. Sklerov, N. Browner, D. Drazheva, E. Dayan (Chapel Hill, NC, USA)

Functional connectivity of the basal ganglia in tremor dominant and non-tremor dominant Parkinson’s disease

S. Prasad, J. Saini, R. Bharath, P. Pal (Bengaluru, India)

Functional connectivity traits in Parkinson’s disease mild cognitive impairment

M. Delgado-Alvarado, V. Ferrer-Gallardo, I. Navalpotro-Gómez, S. Moia, M. Carreiras, C. Caballero-Gaudes, M. Rodríguez-Oroz (Torrelavega, Spain)

Graph theory analysis of dopamine D2 receptor network in Parkinson’s disease patients

A. Mihaescu, J. Kim, S. Cho, M. Diez-Cirarda, M. Valli, Y. Koshimori, A. Strafella (Toronto, ON, Canada)

Hyposmia as a biomarker in patients with Parkinson’s disease and atypical Parkinsonism

S. Kumaran, A. Ankeeta, S. Chaudhary, P. Bhat, V. Goyal (New Delhi, India)

Identifying de novo Parkinson’s disease with optical coherence tomography of the retina: A machine learning classification approach

A. Chrysou, T. Heikka, S. Vander Zee, J. Boertien, N. Jansonius, T. van Laar (Groningen, Netherlands)

Identifying neural signatures of Parkinson’s disease that predict decline in gait and postural control

H. Sigurdsson, A. Yarnall, B. Galna, S. Lord, L. Alcock, R. Morris, R. Lawson, S. Colloby, M. Firbank, N. Pavese, D. Brooks, J. O'brien, D. Burn, L. Rochester (Newcastle upon Tyne, United Kingdom)

Identifying the functional brain network of motor reserve in early Parkinson’s disease

S.J Chung, H.R Kim, J.H Jung, P.H Lee, Y. Jeong, Y.H Sohn (Seoul, Republic of Korea)

Impaired Structural Connectivity in Parkinson’s Disease and its Neuropsychological Correlates

A. Inguanzo, R. Sala-Llonch, C. Junque, A. Abos, A. Campabadal, C. Uribe, H. Baggio, Y. Compta, M. Marti, F. Valldeoriola, B. Segura (Barcelona, Spain)

Impairment of the mesocortical dopamine system in Parkinson’s disease patients with freezing of gait in a multimodal imaging approach

K. Steidel, M. Ruppert, A. Greuel, I. Palaghia, J. Hammes, T. van Eimeren, L. Timmermann, M. Tittgemeyer, A. Drzezga, C. Eggers (Marburg, Germany)

Impulse control disorder and ventral striatum dopamine D3 receptor availability in Parkinson’s disease

G. Pagano, S. Molloy, P. Bain, E. Rabiner, K. Chaudhuri, D. Brooks, N. Pavese (Basel, Switzerland)

Impulse control disorders in Parkinson’s disease: A whole brain morphometric and diffusion tensor study

A. Roux, F. Durif, A. Marques, J. Bonny, B. Pereira (Clermont Ferrand, France)

In vivo markers of anxiety in drug-naïve Parkinson’s disease

H. Wilson, E. de Natale, M. Politis (London, United Kingdom)

Increased attention for food stimuli as a mechanism for weight gain in patients with Parkinson’s disease undergoing DBS of the subthalamic nucleus

J. Steinhardt, H. Hanßen, M. Heldmann, A. Neumann, J. Voges, J. Krauss, V. Tronnier, T. Münte, N. Brüggemann (Lübeck, Germany)

Increased availability of the metabotropic glutamate receptor 5 in the motor system of patients with Parkinson’s disease

C.J Doppler, E. Farrher, C. Régio Brambilla, C.P Filss, J. Lindemeyer, A. Gogishvili, B. Neumaier, M.T Barbe, I. Neuner, C. Lerche, N.J Shah, K.J Langen, G.R Fink, M. Sommerauer (Jülich, Germany)

Inertial-sensor based full-body kinematics reveals an unstable gait with increased variability in patients with evidence of dopaminergic denervation with 123I-FP-CIT SPECT

M. Mendonça, J. Silva, F. Oliveira, A. Oliveira-Maia, J. Ferreira, D. Costa, R. Costa, R. Matias (Lisboa, Portugal)

Inter-network connectivity dynamics underlie compensatory mechanisms in prodromal Parkinson’s disease

A. Droby, N. Omer, M. Artzi, D. Ban-Bashat, M. Hutchison, J. Cederbaum, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)

Intrinsic brain functional connectivity predicts treatment-related motor complications in drug-naive Parkinson’s disease patients

R. De Micco, F. Di Nardo, M. Siciliano, G. Caiazzo, F. Esposito, G. Tedeschi, A. Tessitore (Naples, Italy)

Intrinsic Remodeling of the Fovea is Correlated with Contrast Sensitivity Loss in Parkinson’s Disease

E. Pinkhardt, A. Ding, S. Slotnick, J. Kassubek, A. Ludolph, S. Glazman, I. Selesnick, I. Bodis-Wollner (Ulm, Germany)

Investigating Substantia Nigra Damage using Fully Automated Segmentation of Neuromelanin MRI in Early Parkinson’s Disease

R. Gaurav, R. Valabregue, L. Yahia-Cherif, N. Pyatigorskaya, G. Mangone, E. Biondetti, C. Ewenczyk, M. Hutchison, J.C Corvol, M. Vidailhet, S. Lehéricy (Paris, France)

Iron Imaging as a Diagnostic Tool for Parkinson’s Disease: A Systematic Review and Meta-Analysis

N. Pyatigorskaya, C. Sanz Morere, R. Gaurav, E. Biondetti, R. Valabregue, M. Santin, L. Yahia-Cherif, S. Lehericy (Paris, France)

Leveraging patient-specific models to optimize DBS monopolar review

Y. Pathak, E. Ross, R. Pahwa (Kansas City, KS, USA)

Levodopa Changes Functional Connectivity Patterns in Subregions of the Primary Motor Cortex in Patients with Parkinson’s Disease

Y.S Shen, W. Liu, M.Y Yu, W.L Liu (Nanjing, China)

Levodopa improves tremor symptom by reducing the connectivity between the thalamic subregions and postcentral gyrus in patients with Parkinson’s disease

W.L Liu, Y.S Shen, M.Y Yu, W.L Liu (Nanjing, China)

Levodopa-induced dyskinesias and substantia nigra dopamine D3 receptor availability in Parkinson’s disease

G. Pagano, S. Molloy, P. Bain, E. Rabiner, K. Chaudhuri, D. Brooks, N. Pavese (Basel, Switzerland)

Look Again: The Diagnostic Value of Repeat Dopamine Transporter Imaging

K. Papesh, Z. Mari (Las Vegas, NV, USA)

Magnetic Property Characterization of Deep Gray Matters in Patients with Alzheimer’s diseases, Dementia with Lewy Bodies and Parkinson’s Disease Dementia using Quantitative Susceptibility Mapping

J. Kim, K. Lee, S. Yoo, Y. Oh, S. Koh (Seoul, Republic of Korea)

Microglial activation associated with a faster progression of nigrostriatal dysfunction in patients with isolated REM sleep behavior disorder

K. Stær, A. Iranzo, M. Stokholm, K. Østergaard, M. Serradell, M. Otto, K. Svendsen, A. Pla, D. Vilas, J. Santamaria, A. Møller, C. Gaig, D. Brooks, P. Borghammer, E. Tolosa, N. Pavese (Aarhus N, Denmark)

Microstructural changes in GBA mutation carriers with depression

H. Wilson, E. de Natale, M. Politis (London, United Kingdom)

Motor and cognitive symptoms in parkinsonism are associated with loss of long-range white matter fibers: Structural network changes in Vascular Parkinsonism and Parkinson’s disease

C. Cooper, B. Marebwa, F. Rodriguez-Porcel, T. Turner, G. Revuelta, J. Jensen, V. Hinson, L. Bonilha (Charleston, SC, USA)

Motor cerebellar connectivity and future development of freezing of gait in de novo Parkinson’s disease

J.H Jung, B.H Kim, S.J Chung, H.S Yoo, Y.H Lee, K. Baik, B.S Ye, Y.H Sohn, J.M Lee, P.H Lee (Seoul, Republic of Korea)

Motor network deficits during lower limb movements in Parkinson’s disease

R. Burciu (Newark, DE, USA)

MRI functional connectivity analysis for speech impairment in Parkinson’s disease

J.P Niguet, R. Viard, T. Guichoux, A. Basirat, L. Defebvre, G. Kuchcinski, D. Devos, C. Moreau (Lille, France)

Neural Correlates of Semantic Fluency Deficits in Parkinson’s Disease with Mild Cognitive Impairment

J. Yang, G. Byrne, J. O'Sullivan, K. McMahon, D. Copland, N. Dissanayaka (Herston, Australia)

Neuroimaging Extra-Striatal D2 Receptors in Parkinson’s Disease with Rapid Eye Movement Sleep Behaviour Disorder

M. Valli, SS. Cho, M. Masellis, R. Chen, Y. Koshimori, M. Diez-Cirarda, A. Mihaescu, A. Strafella (Toronto, ON, Canada)

Non-motor network decoupling accompanies conversion to freezing of gait in Parkinson’s disease

N. D'Cruz, S. Chalavi, M. Gilat, A. Nieuwboer (Leuven, Belgium)

Noradrenergic terminal and locus coeruleus cell loss may be uncoupled in Parkinson’s disease – a PET and MRI multi-modal imaging study

M. Kinnerup, C. Doppler, E. Farrher, T. Fedorova, J. Schaldemose, K. Knudsen, R. Isamail, A. Hansen, K. Stær, G. Fink, J. Shah, D. Brooks, A. Nahimi, P. Borghammer, M. Sommerauer (Aarhus, Denmark)

Normative vs. patient-specific brain connectivity in Deep Brain Stimulation

Q. Wang, H. Akram, M. Muthuraman, G. Gonzalez-Escamilla, S. A. Sheth, G. Groppa, N. Vanegas-Arroyave, L. Zrinzo, N. Li, A. Kühn, A. Horn (Berlin, Germany)

Nucleus basalis of Meynert free-water distinguishes and predicts cognitive impairment and longitudinally correlates with cognitive changes in early Parkinson’s disease

T. Guttuso, Jr., D. Tosun, R. Zivadinov, O. Pasternak, D. Weintraub, N. Bergsland (Buffalo, NY, USA)

Parkinson’s Disease Exhibits Longitudinal Increases in beta-Amyloid in the Striatum and Cingulate Gyrus

J. O'Donnell, Y. Zhou, M. Campbell, B. Maiti, J. Perlmutter (Saint Louis, MO, USA)

Parkinson’s disease-related pattern using resting-state functional MRI: Validation and refinement

A. Rommal, A. Vo, K. Schindlbeck, S. Peng, A. Greuel, M. Ruppert, C. Eggers, D. Eidelberg (Manhasset, NY, USA)

Pattern of cerebral perfusion in early de novo Parkinson’s disease with mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging

L. Jin, J. Wang, Y. Zhang, C. Wang, T. He (Shanghai, China)

Predictors of Underlying Neurodegeneration in Drug-Induced Parkinsonism

W. Aamodt, J. Dubroff, G. Cheng, B. Taylor, S. Wood, J. Duda, J. Morley (Philadelphia, PA, USA)

Prefrontal cortical activity and the control of walking in people with freezing of gait

R. Vitorio, S. Stuart, M. Mancini (Portland, OR, USA)

Progression of cortical thinning in Parkinson’s disease

A. Vo, C. Tremblay, S. Rahayel, Y. Yau, A. Dagher (Montréal, QC, Canada)

Quantification of 123I-ioflupane Striatal Uptake and Individual Patient Diagnostic Predictions: Degenerative Parkinson’s disease, Non-Degenerative Parkinsonism and Tremor Disorders

N. Heng, T. Gilbertson, M. Muqit, D. Steele (Dundee, United Kingdom)

Quantitative Evaluation of Iron Content in Idiopathic Rapid Eye Movement Sleep Behavior Disorder

J. Sun, Z. Lai, J. Ma, L. Gao, M. Chen, J. Chen, J. Fang, Y. Fan, Y. Bao, D. Zhang, P. Chan, Q. Yang, C. Y, T. Wu, T. Ma (Beijing, China)

Quantitative Susceptibility Mapping for Differential Diagnosis of Degenerative Parkinsonisms: A Comparison with Morphometric Indexes

S. Mazzucchi, E. Del Prete, M. Costagli, D. Frosini, D. Paoli, G. Donatelli, P. Cecchi, G. Migaleddu, U. Bonuccelli, M. Cosottini, R. Ceravolo (Pisa, Italy)

Quantitative susceptibility mapping images for the parcellation of the Subthalamic Nucleus: a possible role for targeting Deep Brain Stimulation

E. Del Prete, P. Cecchi, D. Frosini, M. Costagli, S. Mazzucchi, G. Donatelli, G. Migaleddu, U. Bonuccelli, M. Cosottini, R. Ceravolo (Pisa, Italy)

Quantitative Susceptibility Mapping may help distinguish patients with Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy with predominant parkinsonism

K. Matsuura, Y. Ii, M. Maeda, K. Tabei, M. Umino, H. Tomimoto, A. Shindo (TSU, Mie, Japan)

Regional free-water differentially associated with glial activation, neuroinflammation, and neurodegeneration in de novo Parkinson’s disease

D. Tosun, R. Ellis (San Francisco, CA, USA)

Resting State Functional and Structural Connectivity Changes of Cerebellum Basal Ganglia Interconnecting Network in Parkinson’s Disease

V. Radhakrishnan, S. Krishnan, B. Thomas, C. Gallea, C. Kesavadas, A. Kishore (Trivandrum, India)

Retinal Pathology in Parkinson’s Disease: A Longitudinal Study with Optical Coherence Tomography

F. Euler, D. Batra, J. Kassubek, E. Pinkhardt (Ulm, Germany)

Retinal thinning and disease worsening in Lewy body diseases

A. Murueta-Goyena, R. Del Pino, M. Galdós, B. Arana, M. Acera, MM. Carmona-Abellán, P. Reyero, B. Tijero, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, N. Ojeda, J. Peña, J.C Gómez-Esteban, I. Gabilondo (Barakaldo, Spain)

Right hemispheric β-amyloid deposition associates with freezing of gait in Parkinson’s disease

P. Kanel, M. Müller, K. Frey, N. Bohnen (Ann Arbor, MI, USA)

Sex differences on dynamic functional connectivity in Parkinson’s disease and healthy controls

M. Diez-Cirarda, I. Gabilondo, N. Ibarretxe-Bilbao, J.C Gomez-Esteban, J. Kim, O. Lucas-Jimenez, R. Del Pino, J. Peña, N. Ojeda, A. Mihaescu, M. Valli, M.A Acera, A. Cabrera, M.A Gomez-Beldarrain, A.P Strafella (Toronto, ON, Canada)

Sex-specific white matter alterations in Parkinson’s disease with mild cognitive impairment

V. Mishra, K. Sreenivasan, D. Cordes, A. Ritter, Z. Mari, I. Litvan, J. Caldwell (Las Vegas, NV, USA)

Spatiotemporal Changes in Substantia Nigra Neuromelanin Content from Prodromal to Clinical Parkinson’s Disease

E. Biondetti, R. Gaurav, L. Yahia-Cherif, G. Mangone, N. Pyatigorskaya, R. Valabrègue, C. Ewenczyk, M. Hutchison, C. François, J.C Corvol, M. Vidailhet, S. Lehéricy (Paris, France)

Structural and microstructural pathology in early de novo Parkinson’s disease patients with depression: An MRI study

E. de Natale, H. Wilson, M. Politis (London, United Kingdom)

Temporal properties of resting-state functional MRI are associated with ON/OFF levodopa MDS-UPDRS III scores in patients with Parkinson’s disease

M. Morrison, A. Lee, S. Wang, A. Martin, I. Bledsoe, J. Ostrem, P. Larson, P. Starr, D. Wang (San Francisco, CA, USA)

Thalamic nuclei volumes and intrinsic thalamic network in motor subtype in Parkinson’s disease

J. Park, H.T Kim (Busan, Republic of Korea)

The association between thinning of cerebral cortex and age of onset in Parkinson’s disease

K. Seo, R. Yokohama, Y. Ito, Y. Nakazato, I. Matunari, H. Matuda, T. Yamamoto (Saitama, Japan)

The clinical significance of the swallow tail sign in distinguishing Parkinson’s disease patients from healthy individuals

J. Prasuhn, A. Neumann, R. Strautz, S. Dreischmeier, F. Lemmer, H. Hanßen, M. Heldmann, N. Brüggemann (Lübeck, Germany)

Tractography of the corticospinal tract in Parkinson’s disease. How does diffusion values vary along tract segments?

R. Guimarães, L. Ramalho, B. Campos, L. Piovesana, P. Azevedo, F. Cendes (Campinas, Brazil)

Utilization of a Visualization Software Tool for Deep Brain Stimulation Programming in a Subset of Subjects with Parkinson’s Disease Who Participated in the INTREPID Randomized Clinical Trial

M. Tagliati, L. Chen, R. Jain (Los Angeles, CA, USA)

Visualization of Nigrosome 1 at 3T MRI and 18F-DOPA PET for the diagnosis of Parkinson´s disease

A. Martin-Bastida, V. Suarez-Vega, P. Dominguez-Echavarri, F. Guillen-Valderrama, I. Aviles-Olmos, J. Arbizu, M. Rodriguez-Oroz (Pamplona, Spain)

White matter microstructural abnormalities in tremor dominant and non-tremor dominant Parkinson’s disease

P. Pal, S. Prasad, J. Saini (Bengaluru, India)